LEADER 02927oam  2200589   450 
001 9910137464103321
005 20230621135339.0
010   $a2-8218-1470-4
010   $a2-7226-0098-6
024 7 $a10.4000/books.cdf.191
035   $a(CKB)3170000000061028
035   $a(SSID)ssj0001541758
035   $a(PQKBManifestationID)11802994
035   $a(PQKBTitleCode)TC0001541758
035   $a(PQKBWorkID)11535624
035   $a(PQKB)11589935
035   $a(WaSeSS)IndRDA00056487
035   $a(FrMaCLE)OB-cdf-191
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/54289
035   $a(PPN)267951019
035   $a(EXLCZ)993170000000061028
100   $a20160829d2010      uy             0
101 0 $afre
135   $aur||#||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 14$aLes nanotechnologies peuvent-elles contribuer à traiter des maladies sévères /$fPatrick Couvreur
210   $cCollège de France$d2010
210 31$aFrance :$cCollège de France Fayard,$d2010
215   $a1 online resource (60 pages) $cdigital file(s)
225 1 $aLec?ons inaugurales ;$v211
300   $aBibliographic Level Mode of Issuance: Monograph
311 08$aPrint version: 9782213654928 
330   $aInaugural lecture delivered on January 21, 2010, Chair of Technological Innovation Liliane Bettencourt (2009-2010). The design of nanotechnologies capable of transporting drugs in the body and releasing them in a specific manner at the level of the site of action makes it possible to increase the therapeutic activity and to reduce the toxicity of many drugs. These ?nanovectors? are capable of protecting the active molecule from degradation by the enzymes of the organism, of targeting it selectively towards the target tissue or cell, and of controlling its release. More specific than traditional pharmaceutical formulations, ?nanomedicines? make it possible to design new therapeutic strategies in the fight against severe diseases: cancers, intracellular infections, metabolic or neurodegenerative diseases, etc. The Chair of Technological Innovation at the Collège de France was created with the support of the Bettencourt-Schueller Foundation.
410  0$aLec?ons inaugurales du Colle?ge de France ;$v211.
606   $aHealth & Biological Sciences$2HILCC
606   $aBiomedical Engineering$2HILCC
610   $ainnovation technologique
610   $amédecine
610   $ananotechnologies
610   $apharmacotechnie
610   $ananomédicament
615  7$aHealth & Biological Sciences
615  7$aBiomedical Engineering
700   $aCouvreur$b Patrick$0802328
801  0$bPQKB
801  2$bUkMaJRU
906   $aBOOK
912   $a9910137464103321
996   $aNanotechnologies peuvent-elles contribuer à traiter des maladies sévères $91803635
997   $aUNINA